MediGene appoints Arnd Christ as Chief Financial Officeras
03/29/2010
(Fox Business)
The biotech company MediGene AG announced that Chief Financial Officer Dr. Thomas Klaue will leave the company for different opinions in strategic directions of the company by mutual consent with the Supervisory Board in May 2010. Dr. Klaue will resign from office after the Annual Shareholders' Meeting on May 11, 2010, and his employment contract will cease in June 2010. Arnd Christ has been chosen to succeed Dr. Klaue as Chief Financial Officer. Mr. Christ has many years' management experience in the biotech and pharmaceuticals industry, and has held his current position as Chief Financial Officer at the Swiss biotechnology company NovImmune since 2007.
